TY - JOUR
T1 - Organic light emitting diode improves diabetic cutaneous wound healing in rats
AU - Wu, Xingjia
AU - Alberico, Stephanie
AU - Saidu, Edward
AU - Rahman Khan, Sazzadur
AU - Zheng, Shijun
AU - Romero, Rebecca
AU - Sik Chae, Hyun
AU - Li, Sheng
AU - Mochizuki, Amane
AU - Anders, Juanita
N1 - Publisher Copyright:
© 2015 by the Wound Healing Society.
PY - 2015/1/1
Y1 - 2015/1/1
N2 - A major complication for diabetic patients is chronic wounds due to impaired wound healing. It is well documented that visible red wavelengths can accelerate wound healing in diabetic animal models and patients. In vitro and in vivo diabetic models were used to investigate the effects of organic light emitting diode (OLED) irradiation on cellular function and cutaneous wound healing. Human dermal fibroblasts were cultured in hyperglycemic medium (glucose concentration 180 mM) and irradiated with an OLED (623 nm wavelength peak, range from 560 to 770 nm, power density 7 or 10 mW/cm2 at 0.2, 1, or 5 J/cm2). The OLED significantly increased total adenosine triphosphate concentration, metabolic activity, and cell proliferation compared with untreated controls in most parameters tested. For the in vivo experiment, OLED and laser (635 ± 5 nm wavelength) treatments (10 mW/cm2, 5 J/cm2 daily for a total of seven consecutive days) for cutaneous wound healing were compared using a genetic, diabetic rat model. Both treatments had significantly higher percentage of wound closure on day 6 postinjury and higher total histological scores on day 13 postinjury compared with control. No statistical difference was found between the two treatments. OLED irradiation significantly increased fibroblast growth factor-2 expression at 36-hour postinjury and enhanced macrophage activation during initial stages of wound healing. In conclusion, the OLED and laser had comparative effects on enhancing diabetic wound healing.
AB - A major complication for diabetic patients is chronic wounds due to impaired wound healing. It is well documented that visible red wavelengths can accelerate wound healing in diabetic animal models and patients. In vitro and in vivo diabetic models were used to investigate the effects of organic light emitting diode (OLED) irradiation on cellular function and cutaneous wound healing. Human dermal fibroblasts were cultured in hyperglycemic medium (glucose concentration 180 mM) and irradiated with an OLED (623 nm wavelength peak, range from 560 to 770 nm, power density 7 or 10 mW/cm2 at 0.2, 1, or 5 J/cm2). The OLED significantly increased total adenosine triphosphate concentration, metabolic activity, and cell proliferation compared with untreated controls in most parameters tested. For the in vivo experiment, OLED and laser (635 ± 5 nm wavelength) treatments (10 mW/cm2, 5 J/cm2 daily for a total of seven consecutive days) for cutaneous wound healing were compared using a genetic, diabetic rat model. Both treatments had significantly higher percentage of wound closure on day 6 postinjury and higher total histological scores on day 13 postinjury compared with control. No statistical difference was found between the two treatments. OLED irradiation significantly increased fibroblast growth factor-2 expression at 36-hour postinjury and enhanced macrophage activation during initial stages of wound healing. In conclusion, the OLED and laser had comparative effects on enhancing diabetic wound healing.
UR - http://www.scopus.com/inward/record.url?scp=84988259270&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84988259270&partnerID=8YFLogxK
U2 - 10.1111/wrr.12258
DO - 10.1111/wrr.12258
M3 - Article
C2 - 25684653
AN - SCOPUS:84988259270
SN - 1067-1927
VL - 23
SP - 104
EP - 114
JO - Wound Repair and Regeneration
JF - Wound Repair and Regeneration
IS - 1
ER -
